Login / Signup

The Botulinum Toxin Innovation: From Powder to Liquid.

Wooshun LeeHyun Ho Jung
Published in: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] (2024)
The shift toward ready-to-use liquid products can mitigate risks related with reconstitution errors and potentially enhancing patient care by saving time and cost associated with medication preparation.
Keyphrases
  • botulinum toxin
  • ionic liquid
  • adverse drug
  • healthcare
  • patient safety
  • human health
  • molecularly imprinted
  • risk assessment
  • quality improvement